Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals

C Smit; RE Wasmann; SC Goulooze; MJ Wiezer; EPA Dongen; Johan Mouton; RJ Bruggemann; Catherijne Knibbe

doi:10.1111/bcp.14144

Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals

C Smit, RE Wasmann, SC Goulooze, MJ Wiezer, EPA Dongen, Johan Mouton, RJ Bruggemann, Catherijne Knibbe

Medical Microbiology & Infectious Diseases

Research output: Contribution to journal › Article › Academic › peer-review

38 Citations (Scopus)

72 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	303-317
Number of pages	15
Journal	British Journal of Clinical Pharmacology
Volume	86
Issue number	2
DOIs	https://doi.org/10.1111/bcp.14144
Publication status	Published - 2020

Research programs

EMC MM-04-28-01
EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bcp.14144

Repub_124075_O-A.pdfFinal published version, 2.81 MB

Cite this

@article{5ce9229c0d894bb5a65d8225a52bf8e2,

title = "Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals",

author = "C Smit and RE Wasmann and SC Goulooze and MJ Wiezer and EPA Dongen and Johan Mouton and RJ Bruggemann and Catherijne Knibbe",

year = "2020",

doi = "10.1111/bcp.14144",

language = "Undefined/Unknown",

volume = "86",

pages = "303--317",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

TY - JOUR

T1 - Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals

AU - Smit, C

AU - Wasmann, RE

AU - Goulooze, SC

AU - Wiezer, MJ

AU - Dongen, EPA

AU - Mouton, Johan

AU - Bruggemann, RJ

AU - Knibbe, Catherijne

PY - 2020

Y1 - 2020

U2 - 10.1111/bcp.14144

DO - 10.1111/bcp.14144

M3 - Article

C2 - 31661553

SN - 0306-5251

VL - 86

SP - 303

EP - 317

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 2

ER -